Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home News

A Global Strategy to Eliminate Cervical Cancer

I'm Online Chat Now
China Hangzhou AllTest Biotech CO.,LTD certification
China Hangzhou AllTest Biotech CO.,LTD certification
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

Company News
A Global Strategy to Eliminate Cervical Cancer
Latest company news about A Global Strategy to Eliminate Cervical Cancer

WHO recommends strengthening lab services to meet a goal of testing 70% of women by 2030.
Global cases of cervical cancer are projected to rise from 570,000 to 700,000 between 2018 and 2030, with annual deaths increasing to 400,000 over the next 10 years. Most affected women are young, poor, and undereducated.
WHO proposed some activities to support countries in expanding testing services for cervical cancer screening and diagnosis, like:
· Introduce simplified testing strategies for screening and diagnosis, linked to treatment uptake.
· Create demand for screening and diagnosis services for cervical cancer, involve community partners.
· Streamline procurement, training, and quality assurance across all national testing services.
· Coordinate forecasting efforts for reagents/analyzers/consumables led by national authorities and implementing partners.
In any case, we are likely to have a greater impact on update/demand for screening and diagnosis if testing can be done quickly and accurately.


Pub Time : 2021-04-28 11:44:08 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: +86 13989889852

Fax: 86-571-56267856

Send your inquiry directly to us